Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours

SIMPLE SUMMARY: Targeting tumour-specific defects in the DNA damage response (DDR) presents an opportunity for new therapeutic approaches to selectively kill cancer cells. Although the therapeutic rationale of DDR-targeted agents initially focused on their actions against tumour cells, these agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutfi, Nura, Galindo-Campos, Miguel Alejandro, Yélamos, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656491/
https://www.ncbi.nlm.nih.gov/pubmed/34885119
http://dx.doi.org/10.3390/cancers13236008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656491/
https://www.ncbi.nlm.nih.gov/pubmed/34885119
http://dx.doi.org/10.3390/cancers13236008

Ejemplares similares